Delivery Order SPE2DB20D3111-SPE2DB25FA9ME
- Not listed
- The Defense Logistics Agency issued a delivery order valued at $3,336.76 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price delivery order was placed under no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. Janumet is a combination medication used to treat type 2 diabetes, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,996.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Janumet 50-1,000 mg tablets (60-count packages). This contract, which is not set-aside and competitively awarded, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania—which is also the place of...
- The Defense Logistics Agency awarded a $5,726.52 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of 1,000 tablets of Janumet 50-1,000 mg, a diabetes medication combining metformin and sitagliptin. This is a firm fixed-price, non-set-aside contract with a completion date of September 15, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child order under a larger contract vehicle,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract with a ceiling value of $4,174.60. This non-set-aside competitive award is a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,448.64 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on April 21, 2025, with an ultimate completion date of April 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on September 8, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $3,223.51. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of September 9, 2025, and is being performed at the contractor's Conshohocken facility. No set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract valued at $13,839.99. The delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 21, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $3,095.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Janumet 50-1,000 mg, a combination diabetes medication. The contract, which was not set aside and competitively awarded, was executed on September 17, 2025, with an ultimate completion date of September 18, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery supporting...
- The Defense Logistics Agency awarded a delivery order valued at $2,239.56 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,610.07 to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 17, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA9MEDelivery Order
The Defense Logistics Agency awarded a $1,799.82 delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitively awarded delivery order leveraging AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Janumet is a combination diabetes medication containing sitagliptin and metformin, commonly prescribed for type 2 diabetes management within military and federal healthcare systems. This delivery order is a child contract executed under AmerisourceBergen's larger $999.999 billion indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX), which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical procurement contracts covering a broad spectrum of pharmaceutical products and medical supplies. The company's federal contracting demonstrates consistent capability in fulfilling competitive procurement requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/15/25 |